AC Immune SA | CIK:0001651625 | 3

  • Filed: 3/20/2018
  • Entity registrant name: AC Immune SA (CIK: 0001651625)
  • Generator: EDGARfilings PROfile
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1651625/000095010318003508/0000950103-18-003508-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1651625/000095010318003508/aciu-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001651625
  • Open this page in separate window: Click

    • ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory

    The following table summarizes non-vested share awards (restricted share and restricted share units) during the year ended December 31, 2017 (no such awards were granted in 2016 and 2015, respectively):

    Grantee Type
    		 
    Number of non-vested share awards granted
    		 
    Vesting conditions
    		 
    Contractual life of non-vested share awards
    Restricted Share Units
    		     
    Directors
    		 
    29,375
    		 
    1 year service from date of grant, annually
    		 
    10 years
    Executives
    		 
    95,957
    		 
    4 years’ service from the date of grant, quarterly
    		 
    10 years
    Restricted Share Awards
    		 
    4,023
    		 
    2.75 years’ service from date of grant, quarterly
    		 
    10 years

     
    Number of
    non-vested shares
    Weighted average
    grant date fair value
    Non-vested at January 1, 2017
    -
    -
    Forfeited during the year
    -
    -
    Cancelled during the year
    -
    -
    Exercised during the year
    -
    -
    Granted during the year
    129,355
    		 
    9.62
    Non-vested at December 31, 2017
    122,014
    		 
    9.59
    Vested at December 31, 2017
    		 
    7,341
    		  
    10.06